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CASE REPORT
Ameloblastoma in the 
mandible
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Rodrigues Laureano Filho3, Luís Portela4, Ricardo 
Holanda Vasconcellos5
INTRODUCTION
The ameloblastoma is an enamel 
tissue tumor, which does not differentiate to 
form the enamel. It is benign and of ecto-
dermic origin. Although considered a benign 
tumor, its clinical behavior can be conside-
red of middle ground, between benign and 
malignant. The tumor is characterized by 
slow but persistent growth and infiltration in 
adjacent tissue1,2.
CASE PRESENTATION
R.T.B., male, 30 years old, came to 
the Department of Maxillo-Facial Surgery 
complaining of a bulging in his left-side man-
dible, which had been enlarging for the past 
ten years. An incisional biopsy was carried 
out through the oral cavity. The pathology 
finding was ameloblastoma. In order to bet-
ter plan access to the lesion and mandible 
reconstruction after tumor exeresis, we made 
a model through the prototyping technique. 
Treatment chose was hemimandibulectomy, 
with mandibular condyle loosening on the 
ipsilateral side, since the tumor had already 
invaded the cortical bone, with immediate 
reconstruction with reconstruction plate and 
condyle coupled to it. Currently the patient 
has been under observation for four years, 
without signs of recurrence (Figure 1).
DISCUSSION
Ameloblastomas are classified in 
unicystic, solid or multicystic, peripheral and 
malignant subtypes in conventional or mul-
ticystic solid (86% of the cases), unicystic (13% 
of the cases) and peripheral or extra-osseous 
(about 1% of the cases)3. Such distinction is 
important because the treatment of a unicystic 
lesion can be more conservative, for it has a 
less aggressive behavior and smaller size than 
its solid or multicystic counterpart4.
Typical ameloblastoma starts insi-
diously as a central bony lesion which is 
slowly destructive; however tends to expand 
the bone instead of punching a hole throu-
gh it. The tumor is rarely painful, unless 
infected and usually does not cause signs 
and symptoms of nerve involvement, even 
when large3.
Radiographically, the most common 
aspect of multicystic ameloblastomas is a 
multilocular lesion; often times described 
as having the appearance of “soap bubbles” 
when large, and are described as honeycomb 
when small. There is frequently a lingual 
cortical and oral expansion, and usually the 
teeth roots adjacent to the tumor are resorbed. 
Unicystic ameloblastomas present a radiolu-
cent image that surrounds the crown of an 
unerupted tooth or, they simply appear as a 
well defined radiotransparent areas3.
Gender distribution as far as ame-
loblastomas are concerned is 1:14,5. The 
age of most frequent onset is the 3rd and 
4th decades of life6. The mandible is about 
four times more affected than the maxilla6. 
About ¾ of mandible tumors are located in 
the mandible ramus and molar teeth. When 
it involves the maxilla, the posterior region is 
also the one most affected, and as it develops, 
the tumor may involve the maxillary sinus 
and the orbit5.
There is a trend to treat unicystic 
ameloblastomas by curettage with 10%-15% 
of recurrence; however, avoiding patient 
mutilation. In the solid or multicystic tumor, it 
is necessary to have radical surgical excision, 
with resection of the affected bone with at le-
ast 15 mm of healthy tissue as safety margin6. 
The mucosa in contact with the tumor must 
be entirely removed, because it may contain 
ameloblastic cells that can contaminate the 
graft during reconstruction1.
It is important to stress the capacity 
the tumor has to develop late recurrences. 
Because of its slow growth, these recurrences 
may take years, and even decades to happen 
after the first surgery1.
FINAL COMMENTS
Thus, we conclude that radical 
surgery is the treatment of choice most of 
the times. We must stress that radiographic 
methods are not able to determine the exact 
disease extension and the recurrence rate is 
close to 100% when not treated properly.
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Figure 1. Postoperative clinical and radiographic aspects, proto-
typing model and postoperative radiographic aspect.
